Coherus Oncology (CHRS) Acquisitions (2014)

Coherus Oncology has disclosed Acquisitions across 1 years of filings, most recently posting $2.3 million for Q1 2014.

• In Q1 2014, Acquisitions changed N/A year-over-year to $2.3 million; the TTM figure through Dec 2014 stood at $2.3 million (changed N/A YoY), while the FY2023 annual figure was $7.0 million, changed N/A from the prior year.
• Acquisitions came in at $2.3 million for Q1 2014 at Coherus Oncology.
• In the past five years, Acquisitions ranged from a high of $2.3 million in Q1 2014 to a low of $2.3 million in Q1 2014.